يعرض 1 - 10 نتائج من 30 نتيجة بحث عن '"Oxford COVID Vaccine Trial Group"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: Print-Electronic; application/pdf

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المصدر: The Lancet , 397 (10277) pp. 881-891. (2021)

    وصف الملف: text

  6. 6
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://openaccess.sgul.ac.uk/id/eprint/116408/1/1-s2.0-S0140673621016998-main.pdfTest; Flaxman, A; Marchevsky, NG; Jenkin, D; Aboagye, J; Aley, PK; Angus, B; Belij-Rammerstorfer, S; Bibi, S; Bittaye, M; Cappuccini, F; et al. Flaxman, A; Marchevsky, NG; Jenkin, D; Aboagye, J; Aley, PK; Angus, B; Belij-Rammerstorfer, S; Bibi, S; Bittaye, M; Cappuccini, F; Cicconi, P; Clutterbuck, EA; Davies, S; Dejnirattisai, W; Dold, C; Ewer, KJ; Folegatti, PM; Fowler, J; Hill, AVS; Kerridge, S; Minassian, AM; Mongkolsapaya, J; Mujadidi, YF; Plested, E; Ramasamy, MN; Robinson, H; Sanders, H; Sheehan, E; Smith, H; Snape, MD; Song, R; Woods, D; Screaton, G; Gilbert, SC; Voysey, M; Pollard, AJ; Lambe, T; Oxford COVID Vaccine Trial group (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet, 398 (10304). pp. 981-990. ISSN 1474-547X https://doi.org/10.1016/S0140-6736Test(21)01699-8 SGUL Authors: Heath, Paul Trafford

  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://openaccess.sgul.ac.uk/id/eprint/116403/1/Correlates%20of%20protection%20against%20symptomatic%20and%20asymptomatic%20SARS-CoV-2%20infection.pdfTest; https://openaccess.sgul.ac.uk/id/eprint/116403/6/41591_2021_1540_MOESM1_ESM.pdfTest; https://openaccess.sgul.ac.uk/id/eprint/116403/11/41591_2021_1540_MOESM2_ESM.pdfTest; Feng, S; Phillips, DJ; White, T; Sayal, H; Aley, PK; Bibi, S; Dold, C; Fuskova, M; Gilbert, SC; Hirsch, I; et al. Feng, S; Phillips, DJ; White, T; Sayal, H; Aley, PK; Bibi, S; Dold, C; Fuskova, M; Gilbert, SC; Hirsch, I; Humphries, HE; Jepson, B; Kelly, EJ; Plested, E; Shoemaker, K; Thomas, KM; Vekemans, J; Villafana, TL; Lambe, T; Pollard, AJ; Voysey, M; Oxford COVID Vaccine Trial Group (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med, 27 (11). pp. 2032-2040. ISSN 1546-170X https://doi.org/10.1038/s41591-021-01540-1Test SGUL Authors: Heath, Paul Trafford

  8. 8
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://researchonline.ljmu.ac.uk/id/eprint/19057/1/Safety%20and%20immunogenicity%20of%20the%20ChAdOx1%20nCoV-19%20%28AZD1222%29%20vaccine%20against%20SARS-CoV-2%20in%20HIV%20infection.pdfTest; Frater, J, Ewer, KJ, Ogbe, A, Pace, M, Adele, S, Adland, E, Alagaratnam, J, Aley, PK, Ali, M, Ansari, MA, Bara, A, Bittaye, M, Broadhead, S, Brown, A, Brown, H, Cappuccini, F, Cooney, E, Dejnirattisai, W, Dold, C, Fairhead, C, Fok, H, Folegatti, PM, Fowler, J, Gibbs, C, Goodman, AL, Jenkin, D, Jones, M, Makinson, R, Marchevsky, NG, Mujadidi, YF, Nguyen, H, Parolini, L, Petersen, C, Plested, E, Pollock, KM, Ramasamy, MN, Rhead, S, Robinson, H, Robinson, N, Rongkard, P, Ryan, F, Serrano, S, Tipoe, T, Voysey, M, Waters, A, Zacharopoulou, P, Barnes, E, Dunachie, S, Goulder, P, Klenerman, P, Screaton, GR, Winston, A, Hill, AVS, Gilbert, SC, Pollard, AJ, Fidler, S, Fox, J, Lambe, T, Oxford COVID Vaccine Trial Group, and Tahmasebi, F (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. The lancet. HIV, 8 (8). e474-e485. ISSN 2405-4704

  9. 9
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://researchonline.lshtm.ac.uk/id/eprint/4663299/1/1-s2.0-S0140673621016998-main.pdfTest; Flaxman, Amy; Marchevsky, Natalie G; Jenkin, Daniel; Aboagye, Jeremy; Aley, Parvinder K; Angus, Brian; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; +28 more. Cicconi, Paola; Clutterbuck, Elizabeth A; Davies, Sophie; Dejnirattisai, Wanwisa; Dold, Christina; Ewer, Katie J; Folegatti, Pedro M; Fowler, Jamie; Hill, Adrian VS; Kerridge, Simon; Minassian, Angela M; Mongkolsapaya, Juthathip; Mujadidi, Yama F; Plested, Emma; Ramasamy, Maheshi N; Robinson, Hannah; Sanders, Helen; Sheehan, Emma; Smith, Holly; Snape, Matthew D; Song, Rinn; Woods, Danielle; Screaton, Gavin; Gilbert, Sarah C; Voysey, Merryn; Pollard, Andrew J; Lambe, Teresa; Oxford COVID Vaccine Trial group; Oxford COVID Vaccine Trial group; (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet (London, England), 398 (10304). pp. 981-990. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736Test(21)01699-8

  10. 10
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://openaccess.sgul.ac.uk/id/eprint/112224/1/1-s2.0-S0140673620316044-main.pdfTest; Folegatti, PM; Ewer, KJ; Aley, PK; Angus, B; Becker, S; Belij-Rammerstorfer, S; Bellamy, D; Bibi, S; Bittaye, M; Clutterbuck, EA; et al. Folegatti, PM; Ewer, KJ; Aley, PK; Angus, B; Becker, S; Belij-Rammerstorfer, S; Bellamy, D; Bibi, S; Bittaye, M; Clutterbuck, EA; Dold, C; Faust, SN; Finn, A; Flaxman, AL; Hallis, B; Heath, P; Jenkin, D; Lazarus, R; Makinson, R; Minassian, AM; Pollock, KM; Ramasamy, M; Robinson, H; Snape, M; Tarrant, R; Voysey, M; Green, C; Douglas, AD; Hill, AVS; Lambe, T; Gilbert, SC; Pollard, AJ; Oxford COVID Vaccine Trial Group (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet, 396 (10249). pp. 467-478. ISSN 1474-547X https://doi.org/10.1016/S0140-6736Test(20)31604-4 SGUL Authors: Heath, Paul Trafford